Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Someone must know something, probably a buyout in the works for Monday.
Dont sell for under 50 a share
They knew the would sell off when the laid the 60 people off. That was 2/3 months ago.
You lay off 60 workers and keep 4 BOD making 400k plus unreal.
You can read it in Ronins first letter.
They are put out there for the reason to put doubt and confusion in peoples minds.
Its a ploy to sway the voting. To make Ronin look bad.
Bid I know you knew this, just some might not.
You mean how this BOD is looking out for the SH here?
For years people didnt know what was going on, hoping for the home run.
Listening to the experts that couldnt be wrong.
BOD deserve a raise.
Soon
Its like Deja Vu all over again.
My Corvair has no heat.
Maybe Ralph Nader has the last puzzle piece.
Thats the problem Rev, you have never had the BOD look you in the eyes and give you that special 3 fingered handshake and side wink or you would understand.
Dont forget the free shcrimp.
You only heard the words ASTRONOMICAL< IMMINENT SOON here.
Bottom of the ninth, two outs no one on
TOG did you forget the 1/5 split most here were involved in before?
http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=416393
8 years to the day it was announced.
Yep Law firm of Dewey Cheatem and Howe. No one is going to file.
Since it is the Microsoft of Biotechs it must be worth 200/300 a share.
Wonder where these guys came up with the idea to sell?
IFU, this is why someone keeps posting to split the votes to confuse SH and send in the white one even if it is just for SK. It negates any other votes.
If I recall JDM saying the courts were not real happy with this BOD in the first place so Im thinking it will go against them.
Its possible, it was posted here yesterday. Ronin didnt pick PPHM by throwing a dart and it hit on PPHM.
They know what they are doing, tell us they are on the up and up if you read their first or second letter to SH.
They say long term and know they can make a buck with AVID.
How much I think depends on how long they stay.
Or you stick with this BOD and get diluted to heck.
No one will deal with the current guys.
Ronin is the only chance to recover any money.
If Ronin pulls out this will be back to 30 cents in a month.
I cant remember, but when they first stated there would be two cards someone said that if you send the white one back last it would negate the blue one?
Was I reading this wrong and might be posting this to early because the scum are holding up the proxies.
If its true, I see why the long paragraph on red this white that blue this.
The answer is BURN THE WHITE CARD
Im sure CP is aware of this dont you think?
Do you think Ronins 3 guys will be YES men and let the BS go on?
The 4 you hope to get in will be jumping ship faster than rats on the Titanic.
You think they will let them continue their business practices and not say anything?
They will have the place running better and after the first year get the rest of the competent people in and PPHM flunkies out.
They already have the BOD heads spinning, wait till they have to sit across from them at a table.
The only thing being said time and time again is Ronin stated WORTHLESS that has been proven here that it was made up.
They said they will see if the IP can be monetized, after getting OUTSIDE experts to evaluate it.
The only thing worthless is the current BOD.
I do think the only scam here is the current BOD handling of this stock and their main one now of screwing the ASM up. IMHO
Read Bernie Madoffs book.
As for digging deaper, I see they are pushing China again.
They really dug deep after getting screwed the first time.
BURN THE WHITE CARD
I am commenting on who you feel brings substance.
If you put out a million puzzle pieces and none happen is that substance?
Again I ask you what happened last time PPHM dealt with China.
Was it substance when the BOYS kept posting no reverse splits both times.
Did they say it wouldnt be 1/7 and write 40 paragraphs why?
Was it substance when they keep posting SOON and Imminent.
Was it substance when they stated this BOD was great and deserved their raise?
All that substance put your investment 90% down.
Its not substance because you want to hear it.
I find it very hard to believe that anyone could be aligned with this BOD unless they had other motives.
Ummm your pattern seems to be broken.
royal jewel is the same as PEARL?
They will just steal it, they dont care.
Lots of maybes in your post.
Do you think all of the sudden they will be good guys?
They do what they want.
Just like the RS, how many times have people said here A deal is probably already done, thats how things are done in business.
Things are done up front , not in back alleys.
If you keep doing behind the back deals they always bite you in the butt.
Like the proxie papers if you know what I mean.
They already made a 60 million dollar blunder, this isnt a game of maybe.
Just so you know China would sell the USA out in a second.
Now Bio, I know you are really good with Watson or google, please refresh my memory of what happened last time PPHM dealt with China?
I mean you are really good of bringing up the past, did you miss this?
https://www.law360.com/ip/articles/21663/california-pharmas-spar-over-chinese-licensing
Geo, exactly my feeling, you would have to think if any BP was interested in PPHM and watching how this is unfolding, they just are backing away.
Unreal, for days the people on the board said Ronin had nothing to do with the climb because it was happening days before the Ronin letter and now it is Ronins pump and dump?
I guess its which side of the bed you got up on huh?
If this Forum words about aggression and violence? bother you here, just think what the RONIN letters must be doing to the BOD.
You came and voiced your not liking it, but the BOD did nothing but hide.
No response. Even people on this forum respond if they are called out but the BOD gets called out so all the BPs can see and hide with their tails between their legs.
They play games with the RS split by turning on the ATM and screwing shareholders because they figured out Ronin was going to boot them out.
They refuse to send out the proxies.
They copy and paste Ronins idea on how to make it profitable and you still have people calling Ronin crooks.
How can this be?
Why do you think BP will not deal with these guys?
I still say if this was what you think, do you think 18 people on IHUB would be the only ones shouting this from the roof tops.
Dont you think all BPs would want the Microsoft of Biotechs?
Now ask yourself why are they not jumping on it?
They have unlimited money that can move trials and not have the botched trials as these guys did.
Ask yourself why they didnt just buy the whole company.
You may be more infatuated with it than most BPs.
20 years 90% loss to SH
BPs will not deal with them
Only hope is Ronin gets in and they will come.
Wook I am not trying to insult you but logic tells me if it was the next Microsoft of Biotechs more people would be touting how great it is.
BPs would have teamed up and we would never of had 2 RS.
They see greed in the BOD pay scale with no return or care about SH.
Look what they did to stop it from going over a buck.
Look what they are doing with the proxies.
If people here see it, dont you think BP executives see 100 times more?
I cant say for Pfizer but I can say with this BOD is a big fat ZEROOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO
Read their letter from yesterday.
Tell me again how they will not be able to add board memers.
Tell me again how we should get someone to open the sealed letters. EGAN
Tell me again how there wont be a RS
Tell me again how Janett Bleecker changed her name
Tell me again how Corning and Nasa are teaming up with PPHM
Tell me again how the 97 collaborations worked out?
Tell me exactly what the SP was when you started posting and what it is now after 2 RS
Tell me when you ever have been right in a prediction.
Go ahead ask Watson
I agree, I dont understand why people didnt see this.
PPHM BOD stopped it from getting to a buck, by turning on the ATM and losing shareholder value, unless a neutral is value.
They knew what RONIN was planning and still cant play chess with them.
They need to spend time in jail and give back tons of cash.
Not only was Ronin the cause for the rise, the scum bags turned the ATM on full blast to prevent this from getting over 1.00
Wook, do you still trust this BOD knowing they turned on the ATM to hold off RONIN knowing they were going to push it over 1.00?
They wanted the split just like they are dead scared of the ASM
Imagine if they didnt let COTARA in P3 sit on the shelf.
They have done nothing on top of the table, everything they do is suspect including FARGO
Here comes the soon and imminent again, which has never worked yet.
The SP rise is because RONINS people are ready to make this make money.
I noticed you used the word junk , was that a slip?
They dont own a big chunk, 8.9 %
RONINS people and friends started buying when they knew EGAN was going to be on the board.
Thats where the price rise and volume came from.
Ronin is respected, this BOD is known as scumbags.
They dont have the brains to address being called bums.
Does anyone here think they didnt turn the ATM on to prevent this from getting over a buck because they figured what RONINS plan were?
Have a good night.
Problem is no one wants to work with the current BOD.
If new guys dont get in kiss your investment goodbye.
Dont worry DART hates to lose.
A repost for everyone that may have missed this today
Ronin Trading and SW Investment Management Announce Additional Nomination to Board of Peregrine Pharmaceuticals
Print
Alert
Peregrine Pharmaceuticals Inc. (MM) (NASDAQ:PPHM)
Intraday Stock Chart
Today : Tuesday 10 October 2017
Click Here for more Peregrine Pharmaceuticals Inc. (MM) Charts.
CHICAGO, Oct. 10, 2017 /PRNewswire/ -- Ronin Trading, LLC and SW Investment Management LLC (together with the other participants in their solicitation, "Ronin" or "we"), collectively the second largest stockholder of Peregrine Pharmaceuticals, Inc. ("Peregrine" or the "Company") (NASDAQ:PPHM), with aggregate beneficial ownership of approximately 8.9% of the Company's outstanding shares of common stock, today issued the following statement with respect to Peregrine.
We are excited to announce our additional nomination of James (Jamie) J. Egan, a 30-year biotech veteran, for election to Peregrine's Board of Directors (the "Board") at the Company's 2017 annual meeting of stockholders (the "2017 Annual Meeting"). We believe Mr. Egan's deep understanding of antibodies, history of senior operations roles at reputable companies in the biotech industry, and proven ability to execute large deals with major pharmaceutical firms make him ideally suited for the Board and a great complement to our previously announced slate of nominees (Gregory P. Sargen, Brian W. Scanlan and Saiid Zarrabian). Mr. Egan's qualifications are discussed in greater detail below.
Ronin has put forth a slate of highly qualified candidates that we believe are capable of delivering stockholder value. Therefore, we are extremely frustrated that the Board continues to needlessly delay the 2017 Annual Meeting, an action that we believe benefits insiders at the expense of stockholders. It has been over ten weeks since Peregrine announced its intention to expand the size of the Board "from four to up to seven members through the addition of new highly-qualified independent directors," yet incredibly, the Board still has not announced a single independent candidate for its slate of nominees. Stockholders should not be punished for the Board's inability to identify qualified independent directors. Furthermore, we are dismayed that Peregrine's first new director candidate, Dr. Roger Lias, is a Company insider rather than an independent member. Not only is it inappropriate for two Company insiders to serve on the Board, but this appointment directly contradicts Peregrine's own statement about adding "independent" directors. We feel these actions are yet more evidence of the extraordinarily poor corporate governance practices at the Company and highlight the need for an overhaul of Peregrine's leadership.
Considering that Peregrine's past 15 annual meetings were held in October, it is blatantly obvious to us that the Company is stalling as a means to entrench the incumbents and insulate them from the will of Peregrine's stockholders. To the extent the Company fails to promptly call the 2017 Annual Meeting, we intend to file suit in accordance with Delaware law to compel the holding of the meeting so we can continue this process of change.
James J. Egan ("Jamie") currently serves as a strategic advisor to Numab AG, a Swiss biotech company that develops antibody-based therapeutics. From 2009 – 2012, Jamie was the Chief Operating Officer of Sucampo Pharmaceuticals, Inc., a publicly-traded global pharmaceutical company, during which time he worked closely with the company's manufacturing partners. Prior to that, Mr. Egan served as Chief Business Officer of ESBATech AG, a privately held Swiss biotechnology company, from 2006 until its acquisition by Alcon S.A. for $589 million in 2009, which Mr. Egan facilitated. From 2001 – 2006, Jamie was Senior VP of Licensing and Corporate Development for biopharmaceutical company Idenix Pharmaceuticals, Inc. ("Idenix"), where he played an instrumental role in Novartis AG's $255 million investment in the company as part of a strategic alliance that allowed Idenix to go public in 2004. Idenix was later acquired by Merck & Co. in 2014 for nearly $3.9 billion. Mr. Egan has also held senior operations roles at pharmaceutical company G.D. Searle & Co. and global healthcare company Abbott Laboratories in the 1980's and 1990's. Prior to becoming a biotech executive, Mr. Egan was a foreign services officer at the US embassy in Tokyo and an attorney with the Department of Justice. Mr. Egan is fluent in Japanese.
CERTAIN INFORMATION CONCERNING THE PARTICIPANTS
Ronin Trading, LLC, together with the other participants named herein (collectively, "Ronin"), has filed a preliminary proxy statement and an accompanying proxy card with the Securities and Exchange Commission ("SEC") to be used to solicit votes for the election of its slate of four highly qualified director nominees at the 2017 annual meeting of stockholders Peregrine Pharmaceuticals, Inc., a Delaware corporation (the "Company").
RONIN STRONGLY ADVISES ALL STOCKHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. SUCH PROXY MATERIALS WILL BE AVAILABLE AT NO CHARGE ON THE SEC'S WEB SITE AT HTTP://WWW.SEC.GOV. IN ADDITION, THE PARTICIPANTS IN THIS PROXY SOLICITATION WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT CHARGE, WHEN AVAILABLE, UPON REQUEST.
The participants in the solicitation are Ronin Trading, LLC ("Ronin Trading"), John S. Stafford, III, SWIM Partners LP ("SWIM Partners"), SW Investment Management LLC ("SW Management"), Stephen White, James J. Egan, Gregory P. Sargen, Brian W. Scanlan and Saiid Zarrabian.
As of the date hereof, Ronin Trading directly beneficially owned 3,310,652 shares of the Company's common stock, $0.001 par value per share ("Common Stock"), including 137,260 shares of Common Stock that may be acquired upon the conversion of 115,299 shares of the Company's 10.50% Series E Convertible Preferred Stock, $0.001 par value per share ("Series E Preferred Stock"). Mr. Stafford, as the Manager of Ronin Trading, may be deemed to beneficially own the 3,310,652 shares of Common Stock beneficially owned directly by Ronin Trading. As of the date hereof, SWIM Partners directly beneficially owned 510,333 shares of Common Stock, including 10,333 shares of Common Stock that may be acquired upon the conversion of 8,680 shares of Series E Preferred Stock. As of the date hereof, an account separately managed by SW Management (the "SW Account") held 203,714 shares of Common Stock, including 3,714 shares of Common Stock that may be acquired upon the conversion of 3,120 shares of Series E Preferred Stock. SW Management, as the general partner and investment adviser of SWIM Partners and the investment adviser of the SW Account, may be deemed to beneficially own the 714,047 shares of Common Stock beneficially owned in the aggregate by SWIM Partners and held in the SW Account. Mr. White, as the Manager of SW Management, may be deemed to beneficially own the 714,047 shares of Common Stock beneficially owned in the aggregate by SWIM Partners and held in the SW Account. As of the date hereof, Messrs. Egan, Sargen, Scanlan and Zarrabian did not beneficially own any securities of the Company.
Investor Contact:
Stephen White
SW Investment Management LLC
(312) 765-7033
View original content:http://www.prnewswire.com/news-releases/ronin-trading-and-sw-investment-management-announce-additional-nomination-to-board-of-peregrine-pharmaceuticals-300534063.html
SOURCE Ronin Trading, LLC and SW Investment Management LLC
Wook , you will see manufacturing when RONIN is in.
They didnt jump in blind. They have someone waiting that will not deal with the current board for their own reasons.
The worst thing that could happen is the current board stays in and this gets diluted forever.
You keep asking for major this and that, has the PPHM board done this in the last 15 years?